As of 2024-12-14, the Relative Valuation of Pulse Biosciences Inc (PLSE) is (27.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.65 USD, the upside of Pulse Biosciences Inc based on Relative Valuation is -253.6%.
The range of the Relative Valuation is (27.75) - (26.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.0x - 41.3x | 38.8x |
| Forward P/E multiples | 31.7x - 35.1x | 33.5x |
| Fair Price | (27.75) - (26.31) | (27.11) |
| Upside | -257.2% - -249.0% | -253.6% |
| Date | P/E |
| 2024-12-13 | -22.66 |
| 2024-12-12 | -22.86 |
| 2024-12-11 | -23.03 |
| 2024-12-10 | -22.23 |
| 2024-12-09 | -24.98 |
| 2024-12-06 | -26.34 |
| 2024-12-05 | -25.02 |
| 2024-12-04 | -26.38 |
| 2024-12-03 | -27.04 |
| 2024-12-02 | -27.84 |
| 2024-11-29 | -28.54 |
| 2024-11-27 | -27.16 |
| 2024-11-26 | -27.07 |
| 2024-11-25 | -23.98 |
| 2024-11-22 | -23.58 |
| 2024-11-21 | -21.50 |
| 2024-11-20 | -21.52 |
| 2024-11-19 | -22.72 |
| 2024-11-18 | -21.98 |
| 2024-11-15 | -22.19 |
| 2024-11-14 | -22.82 |
| 2024-11-13 | -23.19 |
| 2024-11-12 | -23.66 |
| 2024-11-11 | -25.04 |
| 2024-11-08 | -26.50 |
| 2024-11-07 | -23.98 |
| 2024-11-06 | -24.07 |
| 2024-11-05 | -21.96 |
| 2024-11-04 | -20.26 |
| 2024-11-01 | -19.42 |
| 2024-10-31 | -23.24 |
| 2024-10-30 | -23.63 |
| 2024-10-29 | -22.72 |
| 2024-10-28 | -23.46 |
| 2024-10-25 | -23.50 |
| 2024-10-24 | -23.90 |
| 2024-10-23 | -22.46 |
| 2024-10-22 | -23.51 |
| 2024-10-21 | -23.75 |
| 2024-10-18 | -23.07 |
| 2024-10-17 | -23.70 |
| 2024-10-16 | -23.19 |
| 2024-10-15 | -21.86 |
| 2024-10-14 | -22.03 |
| 2024-10-11 | -22.78 |
| 2024-10-10 | -20.80 |
| 2024-10-09 | -20.99 |
| 2024-10-08 | -21.06 |
| 2024-10-07 | -21.62 |
| 2024-10-04 | -21.31 |